Børge Nordestgaard

Børge Nordestgaard

Clinical Professor

Member of:

  • Clinical Biochemistry


Publication year:
All
11 - 20 out of 24Page size: 10
Sort by: Title
  1. Published

    Measuring lipoprotein(a) for cardiovascular disease prevention - in whom and when?

    Thomas, P. E., Vedel-Krogh, S. & Nordestgaard, Børge, 2024, In: Current Opinion in Cardiology. 39, 1, p. 39-48 10 p.

    Research output: Contribution to journal › Review › Research › peer-review

  2. E-pub ahead of print

    Normal values of myocardial blood flow measured with dynamic myocardial CT perfusion

    Møller, M. B., Linde, J. J., Fuchs, A., Køber, Lars Valeur, Nordestgaard, Børge & Kofoed, Klaus Fuglsang, 2024, (E-pub ahead of print) In: European heart journal. Cardiovascular Imaging. jeae050.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment

    Wulff, A. B., Nordestgaard, Børge & Langsted, A., 2024, In: Current Atherosclerosis Reports. 26, 4, p. 111-118 8 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence

    Nielsen, M. B., Çolak, Y., Benn, Marianne, Mason, A., Burgess, S. & Nordestgaard, Børge, 2024, In: Cardiovascular Research. 120, 1, p. 95-107 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Predicting exacerbations in COPD in the Danish general population

    Marott, J. L., Ingebrigtsen, T. S., Çolak, Y., Vestbo, J., Nordestgaard, Børge & Lange, Peter, 2024, In: Respiratory Medicine. 224, 6 p., 107557.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Prevalence of hyperthyroidism and hypothyroidism in liver transplant recipients and associated risk factors

    Suarez-Zdunek, M. A., Arentoft, N. S., Krohn, P. S., Lauridsen, E. H. E., Afzal, Shoaib, Høgh, J., Thomsen, M. T., Knudsen, A. D., Nordestgaard, Børge, Hillingsø, Jens Georg, Villadsen, G. E., Holland-Fischer, P., Rasmussen, A., Fialla, A. D., Feldt-Rasmussen, Ulla & Nielsen, Susanne Dam, 2024, In: Scientific Reports. 14, 1, 9 p., 7828.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study

    Wadström, B. N., Pedersen, K. M., Wulff, A. B. & Nordestgaard, Børge, 2024, In: Arteriosclerosis, Thrombosis, and Vascular Biology. 44, 5, p. 1144-1155 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: Implications for clinical trials

    Elías-López, D., Doi, T., Nordestgaard, Børge & Kobylecki, C. J., 2024, In: Current Opinion in Clinical Nutrition and Metabolic Care. 27, 2, p. 125-135 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial

    Doi, T., Langsted, A. & Nordestgaard, Børge, 2024, In: Atherosclerosis. 393, 9 p., 117556.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Accepted/In press

    SGLT2-inhibition increases total, LDL, and HDL cholesterol and lowers triglycerides: Meta-analyses of 60 randomized trials, overall and by dose, ethnicity, and drug type

    Bechmann, L. E., Emanuelsson, F., Nordestgaard, Børge & Benn, Marianne, 2024, (Accepted/In press) In: Atherosclerosis. 117236.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 11241